Literature DB >> 6972939

Izumenolide-a novel beta-lactamase inhibitor produced by Micromonospora. II. Biological properties.

K Bush, D P Bonner, R B Sykes.   

Abstract

Izumenolide is a potent inhibitor of beta-lactamases, especially from Gram-negative bacteria. The I50 value of 0.01 microgram/ml for TEM-2 beta-lactamase, after 10 min preincubation, corresponds to a ratio of 7.6 moles inhibitor per mole of enzyme. The initial inhibitory reaction with TEM-2 beta-lactamase exhibits mixed reaction kinetics, suggesting a possible overlapping binding site with the active center. Tem-2 beta-lactamase is irreversible inactivated by izumenolide in a biphasic reaction. Carbenicillin offers partial protection against inactivation. Izumenolide exhibits limited antibiotic activity against some Gram-negative bacteria. Against beta-lactamase producing bacteria izumenolide provides protection to ampicillin and cephaloridine but the protection is limited due to permeability problems associated with izumenolide entry into the cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6972939     DOI: 10.7164/antibiotics.33.1262

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  3 in total

Review 1.  Current challenges in antimicrobial chemotherapy: focus on ß-lactamase inhibition.

Authors:  Carine Bebrone; Patricia Lassaux; Lionel Vercheval; Jean-Sébastien Sohier; Adrien Jehaes; Eric Sauvage; Moreno Galleni
Journal:  Drugs       Date:  2010-04-16       Impact factor: 9.546

2.  The inhibition of class C beta-lactamases by boronic acids.

Authors:  T Beesley; N Gascoyne; V Knott-Hunziker; S Petursson; S G Waley; B Jaurin; T Grundström
Journal:  Biochem J       Date:  1983-01-01       Impact factor: 3.857

3.  The Molecular Basis of β-Lactamase Catalysis and Inhibition.

Authors:  A L Fink
Journal:  Pharm Res       Date:  1985-03       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.